Literature DB >> 20819271

Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers.

I Harstad1, B A Winje, E Heldal, F Oftung, G W Jacobsen.   

Abstract

Screening with chest X-ray and the Mantoux test (the tuberculin skin test [TST]) is compulsory for adult asylum seekers who arrive in Norway. In 2005-2006, we included 823 asylum seekers in a study of the QuantiFERON-TB Gold test (QFT-G), and followed them for 23-32 months. Eight subjects with a positive and one with a negative QFT-G test were diagnosed with tuberculosis (TB). The positive (PPV) and negative predictive values (NPV) for TB were respectively 3.3% and 99.8%. The PPV was 2.3% and the NPV 99.1% for TST >or= 15 mm, and the NPV was 99.5% for TST >or= 6 mm in combination with a negative QFT-G.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819271

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  13 in total

Review 1.  A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.

Authors:  Jonathon R Campbell; Jane Krot; Kevin Elwood; Victoria Cook; Fawziah Marra
Journal:  Mol Diagn Ther       Date:  2015-02       Impact factor: 4.074

2.  Latent tuberculosis infection screening in immigrants to low-incidence countries: a meta-analysis.

Authors:  Jonathon R Campbell; Wenjia Chen; James Johnston; Victoria Cook; Kevin Elwood; Jane Krot; Fawziah Marra
Journal:  Mol Diagn Ther       Date:  2015-04       Impact factor: 4.074

Review 3.  Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.

Authors:  Madhukar Pai; Claudia M Denkinger; Sandra V Kik; Molebogeng X Rangaka; Alice Zwerling; Olivia Oxlade; John Z Metcalfe; Adithya Cattamanchi; David W Dowdy; Keertan Dheda; Niaz Banaei
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

4.  Implementation of an interferon-gamma release assay to screen for tuberculosis in refugees and immigrants.

Authors:  Terri Simpson; Julie Tomaro; Cynthia Jobb
Journal:  J Immigr Minor Health       Date:  2013-08

Review 5.  Defining a migrant-inclusive tuberculosis research agenda to end TB.

Authors:  P B Shete; D Boccia; P Dhavan; N Gebreselassie; K Lönnroth; S Marks; A Matteelli; D L Posey; M J van der Werf; C A Winston; C Lienhardt
Journal:  Int J Tuberc Lung Dis       Date:  2018-08-01       Impact factor: 2.373

Review 6.  Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis.

Authors:  Molebogeng X Rangaka; Katalin A Wilkinson; Judith R Glynn; Daphne Ling; Dick Menzies; Judith Mwansa-Kambafwile; Katherine Fielding; Robert J Wilkinson; Madhukar Pai
Journal:  Lancet Infect Dis       Date:  2011-08-16       Impact factor: 25.071

7.  Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection.

Authors:  Christiaan Mulder; Henk van Deutekom; Erik M Huisman; Sophie Toumanian; Ben F P J Koster; Wieneke Meijer-Veldman; Joke H van Loenhout-Rooyackers; Milo Appel; Sandra M Arend; Martien W Borgdorff; Frank van Leth
Journal:  Eur Respir J       Date:  2012-04-10       Impact factor: 16.671

8.  The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa.

Authors:  Hassan Mahomed; Tony Hawkridge; Suzanne Verver; Deborah Abrahams; Lawrence Geiter; Mark Hatherill; Rodney Ehrlich; Willem A Hanekom; Gregory D Hussey
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

9.  Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.

Authors:  Gerd Gran; Jörg Aßmus; Anne Ma Dyrhol-Riise
Journal:  BMC Public Health       Date:  2013-04-17       Impact factor: 3.295

10.  QuantiFERON-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: a cost-effectiveness analysis.

Authors:  Maunank Shah; Kathryn Miele; Howard Choi; Danielle DiPietro; Maria Martins-Evora; Vincent Marsiglia; Susan Dorman
Journal:  BMC Infect Dis       Date:  2012-12-19       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.